Sign in
CompletedNo phase

Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence

Key facts

Who runs it
University of Strathclyde
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
35 people enrolled
Started
23 Mar 2023
Ended
23 Apr 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Cognitive behavioural therapy for insomnia
Record updated
12 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Diagnosed with breast cancer
  • Aged 18 or over
  • Currently prescribed endocrine therapy medication
  • Experience symptoms of insomnia
  • Self-reported nonadherent to ET medication (e.g. forgetting to take, or deliberately taking a break from medication)
  • Proficient in English language
  • Access to videoconferencing

Who cannot take part

  • Received CBT-I within past 12 months
  • Received chemotherapy or radiotherapy within past 4 weeks
  • Undertaking shift work (i.e., irregular or night shifts)
  • Pregnancy or breastfeeding
  • Other unstable physical or mental health problem (including substance misuse)

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to investigate the impact of cognitive behavioural therapy for insomnia on adherence to endocrine therapy medication in breast cancer survivors.

The 2 groups in the trial

  • Cognitive behavioural therapy for insomniaTreatment being tested

    Following randomisation, participants in the intervention group will receive the CBT-I intervention, delivered over 4 weeks.

  • Waitlist controlNo study treatment, for comparison

    Participants in the waitlist condition will complete all measures at the same timepoints as the intervention group. They will receive the CBT-I intervention after completing the 12-week follow-up assessment. This will then be used as a baseline measure for these participants to compare to their post-intervention and follow-up after receiving the treatment.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence: a Mixed Methods Pilot Study
Publications
Record updated
12 December 2025